KR101076209B1 - 고혈당증 치료 또는 예방용 또는 혈당 안정용 효모 세포벽 - Google Patents

고혈당증 치료 또는 예방용 또는 혈당 안정용 효모 세포벽 Download PDF

Info

Publication number
KR101076209B1
KR101076209B1 KR1020067002769A KR20067002769A KR101076209B1 KR 101076209 B1 KR101076209 B1 KR 101076209B1 KR 1020067002769 A KR1020067002769 A KR 1020067002769A KR 20067002769 A KR20067002769 A KR 20067002769A KR 101076209 B1 KR101076209 B1 KR 101076209B1
Authority
KR
South Korea
Prior art keywords
yeast cell
cell wall
agent
hyperglycemia
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020067002769A
Other languages
English (en)
Korean (ko)
Other versions
KR20060037432A (ko
Inventor
루시엔 르사프르
Original Assignee
르사프르 에 꽁빠니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 르사프르 에 꽁빠니 filed Critical 르사프르 에 꽁빠니
Publication of KR20060037432A publication Critical patent/KR20060037432A/ko
Application granted granted Critical
Publication of KR101076209B1 publication Critical patent/KR101076209B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020067002769A 2003-08-11 2004-08-10 고혈당증 치료 또는 예방용 또는 혈당 안정용 효모 세포벽 Expired - Fee Related KR101076209B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03018222 2003-08-11
EP03018222.4 2003-08-11
EP03020253 2003-09-08
EP03020253.5 2003-09-08

Publications (2)

Publication Number Publication Date
KR20060037432A KR20060037432A (ko) 2006-05-03
KR101076209B1 true KR101076209B1 (ko) 2011-10-24

Family

ID=34276722

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067002769A Expired - Fee Related KR101076209B1 (ko) 2003-08-11 2004-08-10 고혈당증 치료 또는 예방용 또는 혈당 안정용 효모 세포벽

Country Status (17)

Country Link
US (2) US7459159B2 (enExample)
EP (1) EP1663266B1 (enExample)
JP (2) JP4808619B2 (enExample)
KR (1) KR101076209B1 (enExample)
AU (1) AU2004267928B2 (enExample)
BR (1) BRPI0413481A (enExample)
CA (1) CA2534791C (enExample)
DK (1) DK1663266T3 (enExample)
EA (1) EA009677B1 (enExample)
ES (1) ES2405934T3 (enExample)
MA (1) MA28072A1 (enExample)
MX (1) MXPA06001741A (enExample)
NO (1) NO20061138L (enExample)
NZ (1) NZ545594A (enExample)
PL (1) PL1663266T3 (enExample)
PT (1) PT1663266E (enExample)
WO (1) WO2005021015A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006117566A (ja) * 2004-10-20 2006-05-11 Asahi Breweries Ltd 糖代謝改善剤
JP2007195444A (ja) * 2006-01-26 2007-08-09 Asahi Food & Healthcare Ltd ダイエット飲食品
EP2062588A4 (en) * 2006-08-24 2011-06-08 Kirin Holdings Kk COMPOSITION FOR TREATING A SKIN CONDITION
JP5238166B2 (ja) * 2007-02-02 2013-07-17 株式会社ヤクルト本社 インターロイキン12産生抑制剤
FR2919187B1 (fr) * 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2949064B1 (fr) * 2009-08-14 2011-10-07 Lesaffre & Cie Nouvelles compositions destinees a la prevention et/ou au traitement du diabete
FR2978967B1 (fr) * 2011-08-09 2020-03-20 Lesaffre Et Compagnie Ecorces de levure enrichies en vitamine d2, compositions les contenant, leur procede de preparation, leurs utilisations et dispositif permettant la mise en oeuvre du procede
MD4216C1 (ro) * 2012-08-15 2013-11-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Tulpină de drojdii Saccharomyces cerevisiae - producătoare de manani
EP3443849A4 (en) * 2016-04-14 2020-01-15 TableMark Co., Ltd. Food composition or combination for lowering blood glucose level or reducing gi value
CN109310725A (zh) * 2016-05-17 2019-02-05 兴人生命科学株式会社 具有糖尿病预防效果的酵母提取物
IT201600069379A1 (it) * 2016-07-04 2018-01-04 Prosol S P A Composizione sostanzialmente costituita da pareti cellulari di lievito e procedimento per la sua preparazione
FI3685681T3 (fi) * 2019-01-23 2024-08-28 Lesaffre & Cie Hiivatuote, ja sitä sisältävä koostumus, käytettäväksi esibioottisena aineena

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19835767A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae
EP1094117A1 (fr) * 1999-10-22 2001-04-25 LESAFFRE et Cie Poudre de mannoprotéines soluble
FR2825004A1 (fr) * 2001-05-22 2002-11-29 Bio Springer Produit dietetique satiant

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
JPS61167622A (ja) * 1985-01-22 1986-07-29 Asahi Breweries Ltd 糖尿病コントロ−ル剤
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
DE69531900T2 (de) * 1993-12-28 2004-09-09 Société des Produits Nestlé S.A. Cerealien enthaltendes lebensmittel mit einem hohen gehalt an löslichen ballaststoffen
DE4413023A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Gewinnung eines Faktors mit insulinartiger Wirkung aus Hefeextrakt
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
US5773426A (en) * 1996-06-07 1998-06-30 Masaki Shirota Proteoglucan and antidiabetic drug thereof
ES2210577T3 (es) * 1996-09-25 2004-07-01 Gracelinc Limited Productos de beta-glucanos y procedimientos de extraccion a partir de cereales.
WO2002002645A1 (en) * 2000-07-03 2002-01-10 Granate Seed Limited COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME
KR20040039195A (ko) * 2001-04-27 2004-05-10 아지노모토 가부시키가이샤 면역강화제
WO2002098440A1 (en) * 2001-06-01 2002-12-12 Ajinomoto Co., Inc. Drugs for diabetes
US20030118989A1 (en) * 2001-12-21 2003-06-26 Carsten Rosenow Differential isolation of cellular content for biological assays

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19835767A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae
EP1094117A1 (fr) * 1999-10-22 2001-04-25 LESAFFRE et Cie Poudre de mannoprotéines soluble
FR2825004A1 (fr) * 2001-05-22 2002-11-29 Bio Springer Produit dietetique satiant

Also Published As

Publication number Publication date
KR20060037432A (ko) 2006-05-03
WO2005021015A1 (fr) 2005-03-10
EP1663266A1 (fr) 2006-06-07
NO20061138L (no) 2006-05-10
US20090022758A1 (en) 2009-01-22
JP2007501829A (ja) 2007-02-01
PL1663266T3 (pl) 2013-07-31
EA200600402A1 (ru) 2006-08-25
US7459159B2 (en) 2008-12-02
JP4808619B2 (ja) 2011-11-02
AU2004267928B2 (en) 2010-10-21
AU2004267928A1 (en) 2005-03-10
EP1663266B1 (fr) 2013-02-20
BRPI0413481A (pt) 2006-10-17
EA009677B1 (ru) 2008-02-28
CA2534791A1 (fr) 2005-03-10
DK1663266T3 (da) 2013-05-13
CA2534791C (fr) 2014-10-28
JP2011178794A (ja) 2011-09-15
US20060257422A1 (en) 2006-11-16
NZ545594A (en) 2009-09-25
MA28072A1 (fr) 2006-08-01
MXPA06001741A (es) 2006-05-12
PT1663266E (pt) 2013-04-30
ES2405934T3 (es) 2013-06-04

Similar Documents

Publication Publication Date Title
US20090022758A1 (en) Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilization of glycemia
JP5530354B2 (ja) 高インスリン血症の治療および/または予防のための酵母細胞壁の使用
CN101810625A (zh) 蒲公英甾醇的应用
TW200831114A (en) Activity enhancer for detoxifying enzyme
JP4305785B1 (ja) プリン体吸収抑制剤及び血中尿酸値低減剤
CN100377719C (zh) 用于治疗或预防高血糖症或用于稳定血糖的酵母细胞壁
US5773426A (en) Proteoglucan and antidiabetic drug thereof
JP2005035954A (ja) 糖質吸収阻害剤及び高血糖防止食品
JP2005263722A (ja) 醸造副産物からの機能性素材の製造方法およびそれにより得られる機能性素材
AU2005242204B2 (en) Remedies for diabetes mellitus
DK2266581T3 (en) PHARMACEUTICAL COMPOSITION OF ANTIBIOTICS AND prebiotics FOR PREVENTION AND TREATMENT OF DYSBIOSE IN ANTIBACTERIAL THERAPY
JP2006117566A (ja) 糖代謝改善剤
WO2022195212A1 (fr) Inhibiteurs glycosidiques de levure
TWI487529B (zh) 用於降低胰島素抗性之組合物

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20141019

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20141019

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000